In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

EUROASPIRE papers soon to be published

Two EUROASPIRE articles are currently in press:

  • Cardiovascular prevention guidelines in daily practice: A comparison of EUROASPIRE I, II and III surveys In 8 European countries. EUROASPIRE Study Group. Lancet 2009 
  • EUROASPIRE III: A survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from twenty two European countries. EUROASPIRE Study Group. Europ J Cardiovasc Prev Rehabilitation 2009

"Adverse lifestyle trends in our coronary patients - more smoking in younger female patients, increasing obesity and central obesity, and diabetes - represents the biggest challenge for professionals leading prevention and rehabilitation programmes. We need to invest in prevention across Europe" says Dr Kornelia Kotseva, Consultant Cardiologist, Imperial College, London.

EUROASPIRE resources: